ICL Research Development from 2010 to 2026

ICL Stock  USD 5.35  0.12  2.19%   
ICL Israel Research Development yearly trend continues to be quite stable with very little volatility. The value of Research Development is projected to decrease to about 62.1 M. From the period between 2010 and 2026, ICL Israel, Research Development regression line of its data series had standard deviation of  13,690,562 and standard deviation of  13,690,562. View All Fundamentals
 
Research Development  
First Reported
2001-09-30
Previous Quarter
19 M
Current Value
16 M
Quarterly Volatility
4.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check ICL Israel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICL Israel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 359.7 M, Interest Expense of 87.3 M or Selling General Administrative of 416.4 M, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0413 or PTB Ratio of 1.22. ICL financial statements analysis is a perfect complement when working with ICL Israel Valuation or Volatility modules.
  
Build AI portfolio with ICL Stock
Check out the analysis of ICL Israel Correlation against competitors.
Historical Research Development data for ICL Israel serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether ICL Israel Chemicals represents a compelling investment opportunity.

Latest ICL Israel's Research Development Growth Pattern

Below is the plot of the Research Development of ICL Israel Chemicals over the last few years. It is ICL Israel's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICL Israel's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Very volatile
   Research Development   
       Timeline  

ICL Research Development Regression Statistics

Arithmetic Mean66,242,645
Geometric Mean64,665,983
Coefficient Of Variation20.67
Mean Deviation10,721,123
Median69,000,000
Standard Deviation13,690,562
Sample Variance187.4T
Range54.4M
R-Value0.03
Mean Square Error199.8T
R-Squared0.0007
Significance0.92
Slope71,879
Total Sum of Squares2998.9T

ICL Research Development History

202662.1 M
202579.3 M
202469 M
202371 M
202268 M
202164 M
202054 M

About ICL Israel Financial Statements

ICL Israel investors utilize fundamental indicators, such as Research Development, to predict how ICL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development79.3 M62.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:
Check out the analysis of ICL Israel Correlation against competitors.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. Market participants price ICL higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ICL Israel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
0.017
Dividend Share
0.17
Earnings Share
0.29
Revenue Per Share
5.465
Quarterly Revenue Growth
0.057
Understanding ICL Israel Chemicals requires distinguishing between market price and book value, where the latter reflects ICL's accounting equity. The concept of intrinsic value—what ICL Israel's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push ICL Israel's price substantially above or below its fundamental value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, ICL Israel's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.